<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="correction" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cell Death Discov</journal-id><journal-id journal-id-type="iso-abbrev">Cell Death Discov</journal-id><journal-title-group><journal-title>Cell Death Discovery</journal-title></journal-title-group><issn pub-type="epub">2058-7716</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38110330</article-id><article-id pub-id-type="pmc">PMC10728203</article-id>
<article-id pub-id-type="publisher-id">1745</article-id><article-id pub-id-type="doi">10.1038/s41420-023-01745-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Correction</subject></subj-group></article-categories><title-group><article-title>Correction: In vitro CRISPR screening uncovers CRTC3 as a regulator of IFN-&#x003b3;-induced ferroptosis of hepatocellular carcinoma</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Li</surname><given-names>Li</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Xing</surname><given-names>Tao</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Chen</surname><given-names>Yiran</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Xu</surname><given-names>Weiran</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Fan</surname><given-names>Bo</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Ju</surname><given-names>Gaoda</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Jing</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Lin</surname><given-names>Li</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9391-0403</contrib-id><name><surname>Yan</surname><given-names>Cihui</given-names></name><address><email>cihuiyan@tmu.edu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7624-4413</contrib-id><name><surname>Liang</surname><given-names>Jun</given-names></name><address><email>liangjun1959@aliyun.com</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4137-2049</contrib-id><name><surname>Ren</surname><given-names>Xiubao</given-names></name><address><email>renxiubao@tjmuch.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0152hn881</institution-id><institution-id institution-id-type="GRID">grid.411918.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 1798 6427</institution-id><institution>Department of Immunology, </institution><institution>Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, </institution></institution-wrap>Tianjin, China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.411918.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 1798 6427</institution-id><institution>Tianjin&#x02019;s Clinical Research Center for Cancer, </institution></institution-wrap>Tianjin, China </aff><aff id="Aff3"><label>3</label>Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03jxhcr96</institution-id><institution-id institution-id-type="GRID">grid.449412.e</institution-id><institution>Department of Oncology, </institution><institution>Peking University International Hospital, </institution></institution-wrap>Beijing, China </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00nyxxr91</institution-id><institution-id institution-id-type="GRID">grid.412474.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 0027 0586</institution-id><institution>Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Oncology, </institution><institution>Peking University Cancer Hospital and Institute, </institution></institution-wrap>Beijing, China </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/050s6ns64</institution-id><institution-id institution-id-type="GRID">grid.256112.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1797 9307</institution-id><institution>Department of Radiation Oncology, </institution><institution>Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, </institution></institution-wrap>Fuzhou, China </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/013xs5b60</institution-id><institution-id institution-id-type="GRID">grid.24696.3f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0369 153X</institution-id><institution>Department of Oncology, </institution><institution>Beijing Tiantan Hospital, Capital Medical University, </institution></institution-wrap>Beijing, China </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01eff5662</institution-id><institution-id institution-id-type="GRID">grid.411607.5</institution-id><institution>Beijing Chao-Yang Hospital, </institution></institution-wrap>Beijing, China </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.411544.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 0196 8249</institution-id><institution>Department of Pathology and Neuropathology, </institution><institution>University Hospital T&#x000fc;bingen, </institution></institution-wrap>T&#x000fc;bingen, Germany </aff></contrib-group><pub-date pub-type="epub"><day>18</day><month>12</month><year>2023</year></pub-date><pub-date pub-type="pmc-release"><day>18</day><month>12</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>9</volume><elocation-id>462</elocation-id><permissions><copyright-statement>&#x000a9; The Author(s) 2023</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><related-article related-article-type="corrected-article" ext-link-type="doi" xlink:href="10.1038/s41420-023-01630-8" id="d32e55"/><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Cancer therapeutic resistance</kwd><kwd>Cancer therapeutic resistance</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Cell Death Differentiation Association (ADMC) 2023</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p id="Par1">Correction to: <italic>Cell Death Discovery</italic> 10.1038/s41420-023-01630-8, published online 4 September 2023</p><p id="Par2">In this article a grant number has been added:</p><p id="Par3">This study was supported by grants from the Natural Science Foundation of China (grant No. 82202882, 81872166, U20A20375), Beijing Natural Science Foundation (grant No. 7232227), Foundation of Peking University International Hospital (grant no.YN2022ZD01, YN2021ZD03), and Beijing Xisike Clinical Oncology Research Foundation (grant no. Y-BMS2019-015).</p><p id="Par4">The original article has been corrected.</p></body></article>
